A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer

Cancer Letters

Volumn 313, Issue 2, 2011, Pages 192-200

  Li, Zesong ^a   Chen, Jiezhong ^b   Chan, Kwok Wah ^c   Qiao, Liang ^c,d   Wong, Benjamin C Y ^c  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Carcinogenesis; CIAP2; Gastric cancer; Gene therapy; Helicobacter pylori

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 2; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

HELICOBACTER PYLORI;

EID: 82655181796     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.007     Document Type: Article

References (48)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
2. Bray F., Sankila R., Ferlay J., Parkin D.M. Estimates of cancer incidence and mortality in Europe in 1995. Eur. J. Cancer 2002, 38:99-166.
3. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., Lai K.C., Hu W.H., Yuen S.T., Leung S.Y., Fong D.Y., Ho J., Ching C.K., Chen J.S., China Gastric Cancer Study Group Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004, 291:187-194.
4. Herrera V., Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin. Microbiol. Infect. 2009, 15:971-976.
5. Fujioka T., Honda S., Tokieda M. Helicobacter pylori infection and gastric carcinoma in animal models. J. Gastroenterol. Hepatol. 2000, 15:D55-D59.
6. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin. North Am. 1993, 22:89-104.
7. Vauhkonen M., Vauhkonen H., Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract. Res. Clin. Gastroenterol. 2006, 20:651-674.
8. Wong B.C., Lam S.K., Ching C.K., Hu W.H., Kwok E., Ho J., Yuen S.T., Gao Z., Chen J.S., Lai K.C., Ong L.Y., Chen B.W., Wang W.H., Jiang X.W., Hou X.H., Lu J.Y. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. J. Gastroenterol. Hepatol. 1999, 14:120-125.
9. Mannick E.E., Schurr J.R., Zapata A., Lentz J.J., Gastanaduy M., Cote R.L., Delgado A., Correa P., Correa H. Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand. J. Gastroenterol. 2004, 39:1192-1200.
10. Hofman V.L., Moreilhon C., Brest P.D., Lassalle S., Le Brigand K., Sicard D., Raymond J., Lamarque D., Hébuterne X.A., Mari B., Barbry P.J., Hofman P.M. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod. Pathol. 2007, 20:974-989.
11. Maeda S., Otsuka M., Hirata Y., Mitsuno Y., Yoshida H., Shiratori Y., Masuho Y., Muramatsu M., Seki N., Omata M. cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem. Biophys. Res. Commun. 2001, 284:443-449.
12. Sepulveda A.R., Tao H., Carloni E., Sepulveda J., Graham D.Y., Peterson L.E. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment. Pharmacol. Ther. 2002, 16:145-157.
13. Nakajima T., Yamashita S., Maekita T., Niwa T., Nakazawa K., Ushijima T. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int. J. Cancer 2009, 124:905-910.
14. Lim J.W., Kim H., Kim K.H. Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells. Int. J. Biochem. Cell Biol. 2003, 35:1284-1296.
15. Doger F.K., Meteoglu I., Ozkara E., Erkul Z.K., Okyay P., Yukselen V. Expression of NF-kappaB in Helicobacter pylori infection. Dig. Dis. Sci. 2006, 51:2306-2309.
16. Son S.H., Kim H.K., Ji J.S., Cho Y.S., Kim S.S., Chae H.S., Choi M.G., Han S.W., Choi K.Y., Chung I.S., Shin O.R. Expression of peroxisome proliferator-activated receptor (PPAR) gamma in Helicobacter pylori-infected gastric epithelium. Korean J. Gastroenterol. 2007, 49:72-78.
17. Ashktorab H., Daremipouran M., Wilson M., Siddiqi S., Lee E.L., Rakhshani N., Malekzadeh R., Johnson A.C., Hewitt S.M., Smoot D.T. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am. J. Gastroenterol. 2007, 102:2135-2146.
18. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol. Ther. 2007, 6:832-839.
19. Tamm I., Kornblau S.M., Segall H., Krajewski S., Welsh K., Kitada S., Scudiero D.A., Tudor G., Qui Y.H., Monks A. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 2000, 6:1796-1803.
20. Dai Y., Qiao L., Chan K.W., Yang M., Ye J., Ma J., Zou B., Gu Q., Wang J., Pang R., Lan H.Y., Wong B.C. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res. 2009, 69:4776-4783.
21. Qiao L., Dai Y., Gu Q., Chan K.W.., Zou B., Ma J., Wang J., Lan H.Y., Wong B.C. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer. Mol. Cancer Ther. 2008, 7:2203-2211.
22. Maeda S., Yoshida H., Mitsuno Y., Hirata Y., Ogura K., Shiratori Y., Omata M. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut 2002, 50:771-778.
23. Wong B.L., Zhu S.L., Huang X.R., Ma J., Xia H.H., Bucala R., Wong B.C., Lan H.Y. Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am. J. Pathol. 2009, 174:1319-1328.
24. Conte D., Holcik M., Lefebvre C.A., Lacasse E., Picketts D.J., Wright E.E., Korneluk R.G. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol. Cell. Biol. 2006, 26:699-708.
25. Endo T., Abe S., Seidlar H.B., Nagaoka S., Takemura T., Utsuyama M., Kitagawa M., Hirokawa K. Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol. Immunother. 2004, 53:770-776.
26. Ferreira C.G., van der Valk P., Span S.W., Jonker J.M., Postmus P.E., Kruyt F.A., Giaccone G. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann. Oncol. 2001, 12:799-805.
27. Espinosa M., Cantu D., Herrera N., Lopez C.M., De la Garza J.G., Maldonado V., Melendez-Zajgla J. Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer 2006, 6:45.
28. James M.A., Lee J.H., Klingelhutz A.J. Human papillomavirus type 16 E6 activates NF-kB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J. Virol. 2006, 80:5301-5307.
29. Yanai A., Hirata Y., Mitsuno Y., Maeda S., Shibata W., Akanuma M., Yoshida H., Kawabe T., Omata M. Helicobacter pylori induces antiapoptosis through binuclear factor-kappaB activation. J. Infect. Dis. 2003, 188:1741-1751.
30. Yuan H., Fu F., Zhuo J., Wang W., Nishitani J., An D.S., Chen I.S., Liu X. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 2005, 24:5069-5678.
31. Yang L. Incidence and mortality of gastric cancer in China. World J. Gastroenterol. 2006, 12:17-20.
32. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1997, 16:6914-6925.
33. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998, 17:2215-2223.
34. Zhang H.G., Wang J., Yang X., Hsu H.C., Mountz J.D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004, 23:2009-2015.
35. Hu S., Yang X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 2003, 278:10055-10060.
36. Hosokawa Y. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Apoptosis 2005, 10:25-34.
37. Zhou H., Du M.Q., Dixit V.M. Constitutive NF-kB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 2005, 7:425-431.
38. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kB control. Proc. Natl. Acad. Sci. USA 1997, 94:10057-10062.
39. Hong S.Y., Yoon W.H., Park J.H., Kang S.G., Ahn J.H., Lee T.H. Involvement of two NF-kB binding elements in tumor necrosis factor alpha-, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 2000, 275:18022-18028.
40. Hung H.S., Wu W.J., Cheng Y.W., Wu M.F., Chang K.L., Lee H. Cooking oil fumes improve lung adenocarcinoma cell survival through c-IAP2 induction. J. Toxicol. Environ. Health A 2005, 68:1525-1535.
41. Volp K., Brezniceanu M.L., Bosser S., Brabletz T., Kirchner T., Gottel D., Joos S., Zornig M. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006, 55:234-242.
42. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 2010, 10:403-414.
43. Miura K., Karasawa H., Sasaki I. cIAP2 as a therapeutic target in colorectal cancer and other malignancies. Expert Opin. Ther. Targets 2009, 13:1333-1345.
44. Petersen S.L., Peyton M., Minna J.D., Wang X. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression. Proc. Natl. Acad. Sci. USA 2010, 107:11936-11941.
45. Gubanski M., Johnsson A., Fernebro E., Kadar L., Karlberg I., Flygare P., Berglund A., Glimelius B., Lind P.A. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial. Gastric Cancer 2010, 13:155-161.
46. Lee K.H., Hur H.S., Im S.A., Lee J., Kim H.P., Yoon Y.K., Han S.W., Song S.H., Oh D.Y., Kim T.Y. RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase. Cancer Lett. 2010, 299:22-28.
47. Msaki A., Sánchez A.M., Koh L.F., Barré B., Rocha S., Perkins N.D., Johnson R.F. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol. Biol. Cell 2011, 22:3032-3040.
48. Prakash M., Kale S., Ghosh I., Kundu GC., Datta K. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction. Cell Signal. 2011, 23:1563-1577.